Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MIC: Ocriplasmin in Pediatric Vitrectomy
NCT00986362Phase 2Completed
- Sponsor
- Oxurion
- Start
- Feb 2010
- Primary completion
- Dec 2011
- Modality
- Therapeutic Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of ocriplasmin in vitreomacular adhesion (VMA), sponsored by Oxurion. Started Feb 2010; status: completed.
02
Drugs
ocriplasmin
03
Conditions
vitreomacular adhesion (VMA)
Beyond the preview
Go deeper on NCT00986362.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00986362.